Monovalent Fab Fragment Labeling for Multiplex Tissue Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current immunohistochemical methods face challenges in detecting multiple targets in paraffin-embedded tissue samples due to issues like background staining, incomplete penetration of large antibody complexes, and limitations in flow cytometry for tumor cell cycle analysis, which affect the accuracy and reproducibility of results.
Innovation Solution
A method combining antigen retrieval and autofluorescence reduction techniques with fluorescent in situ hybridization (FISH) for sensitive detection of multiple targets in biological samples, using monovalent antibody fragments labeled with fluorescent agents to penetrate tissue samples effectively.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If pre-formed antibody-antibody complexes are used for indirect labeling, then detection sensitivity is improved, but complex size increases preventing sufficient tissue penetration
Solution Approach 1:
The patent divides the labeling system into separate components: primary antibodies bind to targets in tissue, then monovalent Fab fragments (labeled with fluorophores) bind to the primary antibodies. This segmentation prevents formation of large crosslinked complexes while maintaining detection sensitivity, as each Fab fragment is much smaller than a complete antibody-antibody complex.
Solution Approach 2:
The patent uses monovalent Fab fragments as intermediary elements between the primary antibodies and fluorophores. These Fab fragments serve as the linking mechanism without forming large complexes, as they bind to only one site on the primary antibody, preventing the crosslinking that would occur with bivalent secondary antibodies.
2Measurement precision
If bivalent secondary antibodies are used for indirect labeling, then detection sensitivity is improved, but crosslinked complexes form causing background staining
Solution Approach 1:
The patent extracts the bivalent binding capability from the labeling system by using only monovalent Fab fragments. This removes the source of crosslinking and background staining while preserving the ability to detect targets through the primary antibody-Fab fragment complex formation.
Solution Approach 2:
The patent employs commercially available monovalent Fab fragment reagents (such as Zenon reagents) that are designed for single-use in the labeling process. These pre-formed Fab-Fluorophore complexes avoid the need for complex bivalent antibody systems and eliminate crosslinking issues.
3Measurement precision
If large antibody complexes are used, then detection capability is improved, but penetration of fixed paraffin embedded tissue is restricted
Solution Approach 1:
The patent segments the labeling complex into small monovalent Fab fragments that can penetrate tissue effectively. The primary antibody remains small and uncomplexed during penetration, then the small Fab fragment binds to it in situ, ensuring rapid tissue penetration without the hindrance of large pre-formed complexes.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables highly sensitive and accurate simultaneous detection of multiple targets in paraffin-embedded tissue sections, improving the detection of intracellular antigens and providing biologically meaningful data on tumor cell heterogeneity and proliferation markers.
Implementation Method 1
The direct labeling method utilizes a primary antibody (an antibody that recognizes the target) which is then coupled to the fluorescent agent. This method is labor-intensive and a certain amount of antibody might be inactivated in the process (if the label attaches itself to the antigen recognizing region of the antibody).
Implementation Method 2
The antibody binds specifically to the target molecule so that the fluorescent label qualitatively and/or quantitatively reports the presence of the target.
Implementation Method 3
The indirect method utilizes a secondary antibody - an antibody which recognizes the primary antibody - coupled to a fluorescent agent to attach the label.
Implementation Method 4
Others have modified this method by utilizing Fab fragments that recognize both the Fc and f(ab')2 regions of the primary antibody (Brown et al. 2004).
Data Source
Figure 1
Figure 2
Figure 3
AI summary
A method of in situ immunohistochemical analysis of a biological sample is provided. The method allows for the multiplex and simultaneous detection of multiple antigens, including multiple nuclear antigens, in a tissue sample.